It doesnt really matter anymore if Canntab "was" GMP the bigger question now is "will it be" GMP standard.
First we need to find out if they are looking at getting a licence to produce Canntab in Thailand. If someone can ask at the AGM that would be good.
Are they looking at manufacturing Canntab in Thailand under license? If the answer is "possibly" or better that's a good sign. I can then allocate it as a CGB asset again. It has big potential I think.
- Forums
- ASX - By Stock
- CGB
- Ann: Request for Extension of Voluntary Suspension
Ann: Request for Extension of Voluntary Suspension, page-134
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)